Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

Article Details

Citation
Copy to clipboard

Kaplan FS, Al Mukaddam M, Stanley A, Towler OW, Shore EM

Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

Bone. 2020 Nov;140:115539. doi: 10.1016/j.bone.2020.115539. Epub 2020 Jul 27.

PubMed ID
32730934 [ View in PubMed
]
Abstract

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder of extraskeletal bone formation, but could appropriately be viewed as a seminal disorder of osteochondrogenesis. Many, if not most, of the musculoskeletal features of FOP are related to dysregulated chondrogenesis including abnormal articular cartilage formation, abnormal diarthrodial joint specification, growth plate dysplasia, osteochondroma formation, heterotopic endochondral ossification (HEO), and precocious arthropathy. In FOP, causative activating mutations of Activin receptor A type I (ACVR1), a bone morphogenetic protein (BMP) type I receptor, are responsible for the osteochondrodysplasia that impacts developmental phenotypes as well as postnatal features of this illustrative disorder. Here, we highlight the myriad developmental and postnatal effects on osteochondrogenesis that emanate directly from mutant ACVR1 and dysregulated bone morphogenetic protein (BMP) signaling in FOP.

DrugBank Data that Cites this Article

Drugs